Identification of CD 133+ Cells in Pituitary Adenomas
Identification of CD 133+ Cells in Pituitary Adenomas
复制标题
垂体腺瘤中 CD 133 细胞的鉴定
DOI：
10.1159/000330625
复制
发表时间：
2011
影响因子：
4.1
通讯作者：
Hirano H
中科院分区：
文献类型：
--
作者：
Yunoue S;Arita K;Kawano H;Uchida H;Tokimura H;Hirano H
肿瘤中的干细胞样细胞具有自我更新和多向分化的能力，在肿瘤的发生和维持中起重要作用。恶性胶质瘤中的干细胞样细胞表达CD 133。我们用常规免疫组化和生化方法检测了人垂体腺瘤（一种通常为良性的肿瘤）的CD 133表达。我们对70例垂体腺瘤（临床无功能腺瘤和生长激素、催乳素、促肾上腺皮质激素和促甲状腺激素腺瘤）的研究表明，18例（25.7%）表达CD 133。临床无功能性腺瘤的发生率（33.3%）高于功能性腺瘤（12.0%）（p= 0.085）。实时荧光定量PCR检测CD 133阳性标本中CD 133 mRNA的表达。患者年龄、性别、肿瘤大小、术后复发率与CD 133阳性率均无相关性。CD 133+细胞普遍共表达CD 34、巢蛋白和VEGFR 2（KDL 1）。S-100和GFAP不与CD 133共表达。嗜铬粒蛋白A、Pit-1、SF-1和NeuroD 1均为免疫阴性，表明CD 133+细胞不具有分化为功能性内分泌细胞的潜力。我们的数据表明，CD 133在垂体腺瘤中的表达与未成熟的内皮祖细胞有关，这些内皮祖细胞可能在垂体腺瘤的新生血管形成中发挥作用。需要进一步的研究来阐明CD 133+细胞在垂体腺瘤中的新生血管形成和可持续生长方面的意义。
Stem-like cells in tumors are capable of self-renewal and pluri-differentiation; they are thought to play important roles in tumor initiation and maintenance. Stem-like cells in malignant glioma express CD133. We examined samples from human pituitary adenoma, a generally benign neoplasm, for CD133 expression using routine immunohistochemical and biochemical methods. Our study of 70 pituitary adenomas (clinically nonfunctioning adenomas and growth hormone-, prolactin-, adrenocorticotropic hormone-, and thyroid-stimulating hormone-producing adenomas) showed that 18 (25.7%) expressed CD133. This rate was higher in clinically nonfunctioning (33.3%) than functioning adenomas (12.0%)(p= 0.085). Real-time PCR assay revealed the expression of CD133 mRNA in samples immunohistochemically positive for CD133. Neither the patient age and gender, nor the tumor size or postoperative recurrence rate correlated with CD133 positivity. CD133+ cells ubiquitously coexpressed CD34, nestin, and VEGFR2 (KDL1). S-100 and GFAP were not coexpressed with CD133. Chromogranin A, Pit-1, SF-1, and NeuroD1 were immune-negative, indicating that CD133+ cells did not have the potential to differentiate into functional endocrine cells. Our data suggest that the expression of CD133 in pituitary adenomas is related to immature endothelial progenitor cells that may play a role in the neovascularization of pituitary adenomas. Further studies are needed to elucidate the significance of CD133+ cells with respect to neovascularization and their sustainable growth in pituitary adenomas.